Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: RealMuLan who wrote (25225)	3/9/2005 3:52:44 PM
From: RealMuLan	Respond to of 116555

Medicare resurfaces as entitlement titan Amid Social Security debate, this week's news on drug-benefit costs hint at a $27 trillion Medicare obligation. By Gail Russell Chaddock \| Staff writer of The Christian Science Monitor WASHINGTON – As President Bush stumped the case for Social Security reform, the talk on Capitol Hill this week often reverted to what many are calling a more urgent threat to the nation's fiscal health: the soaring liabilities in Medicare, especially its new prescription drug benefit. Sold to Congress as a $400 billion add-on, the 10-year estimate for prescription drug coverage for seniors soared to $723 billion in the president's fiscal 2006 budget. To the green-eyeshade types who track such things, the higher estimate was no surprise: It's the first to include a full 10 years of the new drug benefit. csmonitor.com